Filing Details
- Accession Number:
- 0001209191-21-013482
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 19:43:08
- Reporting Period:
- 2021-02-22
- Accepted Time:
- 2021-02-23 19:43:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1754068 | Allovir Inc. | ALVR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1681782 | R Brett Hagen | C/O Allovir, Inc. 139 Main Street, Suite 500 Cambridge MA 02142 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-02-22 | 800 | $43.14 | 64,765 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.39. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.